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The goal of the Georgia Sickle Cell Data Collection (SCDC) Program is to improve
the quality of life, life expectancy, and the health of individuals with sickle cell
disease (SCD).

By collecting and analyzing health information from patients with SCD over time,
SCDC can identify critical gaps in diagnosis, treatment, and access to care and
can inform decision-makers about how these gaps can be filled through policy
changes, improved health care practices, and education.
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Available SCDC data
As the data coordinating center for SCDC in
Georgia, the Georgia Health Policy Center
at Georgia State University is assembling
a comprehensive dataset that enables
surveillance of sickle cell–related diagnosis
and health care utilization since 2004 for more
than 10,000 patients. Data are collected from:
•
•
•
•

Newborn screening results
Death records
Clinical records from the sickle cell treatment centers
Administrative claims from Georgia’s Medicaid, Children’s Health Insurance
Program, and the State Health Benefit Plan
• Hospital and emergency department discharge data
Why is SCDC important?
SCDC data can help answer questions about access to care, health care utilization
and costs, and quality of care, as well as how these patterns vary by age, sex,
genotype, geography, and health insurance. This information can assist in:
•
•
•
•

Estimating the cost impacts of policy decisions
Informing allocation of outpatient and telehealth services
Targeting patient and family education materials and case management
Focusing provider education and training

SCDC analysis can inform action:
•
•
•
•

Educate — To shape individual or institutional practices or behaviors
Decide — To inform policy, service, and resource allocation decisions
Learn — To answer research questions to inform future actions
Target — To identify a population for interventions, services, or education

Stakeholders who can drive action using SCDC data include:
• Patients and their support circles
• Individual health care providers

• Health systems
• Policymakers
• Payers

National SCDC priority areas:
• Aging sickle cell population —
Documentation of complications,
comorbidities, and outcomes over
patients’ life course can inform standards
of care, interventions, reimbursement,
and health care policy.
• Geography of population — Data can
identify differences in access to care,
health care utilization, and quality of care
by patient location.
• Hispanic population — Data can better identify individuals with SCD born
outside of the United States and estimate the prevalence in the Hispanic
population.
• Transition from pediatric to adult care — Data enables examination of the
factors that may be associated with increases in symptoms, complications,
and poorer outcomes seen during the transition to adult care.
• Utilization — SCDC enables comparisons between low and high utilizers by
diagnosis, procedure or intervention, and outcomes over time. Such analysis
may inform clinical practice and patient self-care tied to better outcomes
and lower costs.
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SCDC Georgia
The Georgia Health Policy Center is the data-coordinating
center for multi-institutional projects focused on surveillance
of and health promotion for individuals with blood
disorders, including SCD.
Learn more: ghpc.gsu.edu/project/hemoglobin-disordersdata-coordinating-center/
Contact Angie Snyder (angiesnyder@gsu.edu) if you would
like to use SCDC Georgia data for your research or planning.
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